The insulin analog aspart: a safe alternative in insulin allergy.
Airaghi
L
L
Lorini
M
M
Tedeschi
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000097:blood / Q000175:diagnosis; D005938:Glucocorticoids / Q000009:adverse effects; D006636:Histamine Release; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007073:Immunoglobulin E / Q000097:blood; D007328:Insulin / Q000031:analogs & derivatives / Q000276:immunology* / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000097:blood; D061267:Insulin Aspart; D008297:Male; D008875:Middle Aged; D012882:Skin Tests
D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007328:Insulin; D007330:Insulin Antibodies; D007073:Immunoglobulin E; D061267:Insulin Aspart